Altimmune Ownership | Who Owns Altimmune?


OverviewForecastRevenueFinancialsChartTranscripts

Altimmune Ownership Summary


Altimmune is owned by 45.94% institutional investors, 0.78% insiders, and 53.28% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.82% of ALT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.36% of its assets in Altimmune shares.

ALT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAltimmune45.94%0.78%53.28%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.37M7.82%$24.66M
Ameriprise financial5.25M7.39%$37.89M
Vanguard group4.43M6.23%$31.95M
State street3.47M4.88%$25.02M
Tang capital management2.75M3.38%$10.64M
Geode capital management1.66M2.33%$11.96M
Millennium management1.11M1.47%$5.56M
Knoll capital management1.12M1.38%$4.34M
Caption management980.78K1.20%$3.80M
Ubs group719.55K1.01%$5.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management1.12M3.09%$4.34M
Gerber206.78K0.56%$800.23K
Tang capital management2.75M0.54%$10.64M
Beirne wealth consulting services342.46K0.43%$1.33M
Brown wealth management231.08K0.28%$894.29K
Scientech research254.31K0.24%$984.19K
Kraematon investment advisors30.79K0.22%$221.96K
Avidity partners management lp105.00K0.08%$406.35K
Summit financial wealth advisors96.29K0.06%$372.63K
Wealth effects31.75K0.05%$122.87K

Top Buyers

HolderShares% AssetsChange
Ameriprise financial5.25M0.01%1.38M
Caption management980.78K0.04%941.92K
Millennium management1.11M0.00%765.66K
Ubs group719.55K0.00%437.10K
Scientech research254.31K0.24%254.31K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp22.10K0.00%-1.15M
Bellevue group---1.06M
Schroder investment management group---961.88K
Capital fund management---726.83K
Vanguard group4.43M0.00%-552.25K

New Positions

HolderShares% AssetsChangeValue
Scientech research254.31K0.24%254.31K$984.19K
Avidity partners management lp105.00K0.08%105.00K$406.35K
Susquehanna portfolio strategies84.33K0.01%84.33K$326.35K
Verition fund management31.15K0.00%31.15K$120.57K
Kraematon investment advisors30.79K0.22%30.79K$221.96K

Sold Out

HolderChange
Capital performance advisors llp-11.00
Tradewinds capital management-20.00
Quantbot technologies lp-60.00
Stephens consulting-65.00
Corecap advisors-71.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252077.81%37,429,392-1.85%451.80%11540.24%39-29.09%
Mar 31, 20257-96.55%2,264,429-94.40%20.09%2-98.15%2-95.12%
Dec 31, 20241978.84%39,287,627-0.54%551.79%10425.30%41-4.65%
Sep 30, 2024180-4.26%39,499,260-6.80%551.56%83-17.82%43-6.52%
Jun 30, 20241882.73%42,381,900-4.54%591.04%101-4.72%4612.20%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.58M3.36%-
Vanguard Total Stock Mkt Idx Inv2.73M3.20%-60.39K
iShares Russell 2000 ETF1.85M2.10%-
SPDR® S&P Biotech ETF1.24M1.41%2.77K
CT (Lux) American Smaller Com 9U USD830.56K1.08%-2.54M
Vanguard Institutional Extnd Mkt Idx Tr882.28K1.04%-406.50K
Fidelity Small Cap Index775.64K0.88%59.16K
Bellevue Healthcare Ord600.00K0.84%600.00K
iShares Russell 2000 Growth ETF673.20K0.76%-
Federated Hermes MDT Small Cap Core IS591.29K0.73%518.67K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2025Sohn Catherine A.-Buy$5.78K
Mar 13, 2025WEAVER GREGORY L Chief Financial OfficerBuy$52.00K
Aug 19, 2024Drutz David-Sell$56.31K
Aug 19, 2024Drutz David-Sell$54.24K
Aug 15, 2023Drutz David-Buy$862.50

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q12-
2024 Q4--
2024 Q3-2

ALT Ownership FAQ


Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 45.94%, followed by 0.78% insiders and 53.28% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 307.10%, which Altimmune falls below.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Blackrock funding, inc. /de (6.37M shares, 7.82%), Ameriprise financial (5.25M shares, 7.39%), and Vanguard group (4.43M shares, 6.23%). Together, they hold 21.45% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

BlackRock is not among the top 10 institutional shareholders of Altimmune.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Altimmune’s biggest shareholder by percentage of total assets invested, with 3.09% of its assets in 1.12M Altimmune shares, valued at 4.34M$.

Who is the top mutual fund holder of Altimmune shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Altimmune shares, with 3.36% of its total shares outstanding invested in 2.58M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools